ReviewESC heart failure2021
Insights into heart failure hospitalizations, management, and services during and beyond COVID-19.
Review in ESC heart failure, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05416879 (Lifestyle Behaviours of Women Newly Diagnosed With Heart Failure), which is not on this map. Cited by 17 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Lifestyle Behaviours of Women Newly Diagnosed With Heart Failure: A Quantitative and Qualitative Approach
Who cites it
17 citing papers in PubMed.
- Obesity Is Associated with a Lower Risk of Mortality and Readmission in Heart Failure Patients with Diabetes.Biomedicines · 2025Article
- Elevated Troponins after COVID-19 Hospitalization and Long-Term COVID-19 Symptoms: Incidence, Prognosis, and Clinical Outcomes-Results from a Multi-Center International Prospective Registry (HOPE-2).Journal of clinical medicine · 2024Article
- The Evolving Phenotypes of Cardiovascular Disease during COVID-19 Pandemic.Cardiovascular drugs and therapy · 2023Review
- Post-COVID-19 Symptoms and Heart Disease: Incidence, Prognostic Factors, Outcomes and Vaccination: Results from a Multi-Center International Prospective Registry (HOPE 2).Journal of clinical medicine · 2023Article
- Clinical Pathways Guided by Remotely Monitoring Cardiac Device Data: The Future of Device Heart Failure Management?Arrhythmia & electrophysiology review · 2023Review
- Impact analysis of heart failure across European countries: an ESC-HFA position paper.ESC heart failure · 2022Review
- COVID-19, cardiac involvement and cardiac rehabilitation: Insights from a rehabilitation perspective - State of the Art.Turkish journal of physical medicine and rehabilitation · 2022Review
- Infodemiological study on the impact of the COVID-19 pandemic on increased headache incidences at the world level.Scientific reports · 2022Article
- Factors Affecting Patient and Physician Engagement in Remote Health Care for Heart Failure: Systematic Review.JMIR cardio · 2022Review
- Economic Issues in Heart Failure in the United States.Journal of cardiac failure · 2022Review
- The year in cardiovascular medicine 2021: heart failure and cardiomyopathies.European heart journal · 2022Article
- Evidence Based Management of Acute Heart Failure in the Era of COVID-19 Pandemic.Intensive care research · 2022Review
- The impact of the Covid-19 pandemic on adult diagnostic neuroradiology in Europe.Neuroradiology · 2022Article
- The Waiting is the Hardest Part: Social Isolation and Delayed Healthcare Delivery During the COVID-19 Pandemic.Journal of cardiothoracic and vascular anesthesia · 2021Article
- Multiparameter diagnostic sensor measurements in heart failure patients presenting with SARS-CoV-2 infection.ESC heart failure · 2021Article
- Insights into heart failure hospitalizations, management, and services during and beyond COVID-19.ESC heart failure · 2021Review
- Perceptions of changes in practice patterns and patient care among heart failure nurses during the COVID-19 pandemic.Heart & lung : the journal of critical careArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus-2. The clinical presentation of this virus mainly manifests in the respiratory system but may also lead to severe complications in the cardiovascular system. The global burden of COVID-19 has led to an unprecedented need to gain further insight into patient outcomes, management, and clinical practice. This review aims to provide an overview of the current literature on heart failure (HF) hospitalizations, management, and care pathways for supporting patients during and beyond this pandemic. A literature review of five areas of interest was conducted and included: (i) HF hospitalization; (ii) recognizing the needs and supporting HF patients during COVID-19; (iii) supporting rehabilitation services; (iv) transitioning to a telehealth framework; and (v) the need for evidence. Patients with new-onset or existing HF are particularly vulnerable, but a significant reduction in HF hospital admissions has been reported. During these periods of uncertainty, the current care pathways for acute and elective cardiac patients have had to change with the relocation of HF services to protect the vulnerable and reduce transmission of COVID-19. Optimizing community HF services has the potential to reduce the pressures on secondary care during the recovery from this pandemic. Telemedicine and virtual health care are emerging technologies and overcome the risk of in-person exposure. Successful remote delivery of cardiac rehabilitation services has been reported during the pandemic. Delivery of a robust telehealth framework for HF patients will improve communication between clinician and patient. The reduction in HF admissions is a concern for the future and may result in unintended mortality. New-onset and current HF patients must understand their diagnosis and future prognosis and seek help and support using the appropriate platform when needed. Realigning HF services and the use of telemedicine and virtual health care has great potential but needs to be carefully understood to ensure engagement and approval in this population to overcome barriers and challenges.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.